DUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported fourth-quarter profit of $191.1 million.
The Dublin-based company said it had profit of $3.11 per share. Earnings, adjusted for one-time gains and costs, were $6.60 per share.
The results topped Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $5.79 per share.
The drugmaker posted revenue of $1.09 billion in the period, also surpassing Street forecasts. Ten analysts surveyed by Zacks expected $1.06 billion.
For the year, the company reported profit of $560.1 million, or $8.65 per share. Revenue was reported as $4.07 billion.
Jazz expects full-year earnings in the range of $22.50 to $24 per share, with revenue in the range of $4.15 billion to $4.4 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.